Treatment for Transient Ischemic Attack (TIA)
All TIA patients require immediate antiplatelet therapy and urgent cardiovascular risk factor management to prevent stroke, which carries a high early recurrence risk of 10-20% within 90 days. 1
Immediate Management (First 24-48 Hours)
Hospitalization Decision
- Admit patients with any of the following high-risk features: TIA within past 24-48 hours, crescendo TIAs, symptoms lasting >1 hour, symptomatic carotid stenosis >50%, known cardiac embolic source (atrial fibrillation), or known hypercoagulable state 1
- For outpatient management, establish specialized TIA clinic evaluation within 24-48 hours for high-risk patients (ABCD2 score ≥4) 1
- Calculate ABCD2 score: Age ≥60 years (1 point), Blood pressure ≥140/90 mmHg (1 point), unilateral weakness (2 points) or speech impairment without weakness (1 point), Duration ≥60 minutes (2 points) or 10-59 minutes (1 point), Diabetes (1 point) 1
Urgent Diagnostic Workup
- Obtain brain MRI (preferred over CT), carotid imaging (duplex ultrasound, CTA, or MRA), ECG, and laboratory studies (CBC, electrolytes, renal function, lipids, glucose) immediately 1
- Brain MRI is superior for detecting silent infarcts and determining stroke mechanism 1
- If carotid duplex results are unreliable or discordant with clinical suspicion, proceed immediately to MRA or CTA 1
Antiplatelet Therapy for Noncardioembolic TIA
First-Line Treatment
- Start antiplatelet therapy immediately upon TIA diagnosis—never delay while awaiting diagnostic workup 1
- Preferred regimen: Aspirin 50mg plus extended-release dipyridamole 200mg twice daily, which reduces stroke risk more effectively than aspirin alone without increasing bleeding risk 1
- Alternative: Clopidogrel 75mg daily, particularly for patients with peripheral arterial disease or prior MI 1
- For acute management, aspirin 160-325mg should be initiated within 24-48 hours 2
Critical Pitfall
- Never combine aspirin and clopidogrel for long-term therapy after TIA—bleeding risk outweighs any potential benefit 1
Anticoagulation for Cardioembolic TIA
- For atrial fibrillation (persistent or paroxysmal): Initiate oral anticoagulation with target INR 2.5 (range 2.0-3.0) 1
- For mechanical prosthetic heart valves: Target INR 3.0 (range 2.5-3.5) 1
- Oral anticoagulation is superior to aspirin or combination aspirin-clopidogrel therapy for stroke prevention in atrial fibrillation 2
Blood Pressure Management
- Start blood pressure-lowering medication 7-14 days after TIA (unless symptomatic hypotension present) 2, 1
- Target blood pressure: <140/90 mmHg for non-diabetics, <130/80 mmHg for diabetics 2, 1
- First-line therapy: ACE inhibitor alone or combined with thiazide diuretic; use angiotensin receptor blocker if ACE inhibitor not tolerated 2, 1
- For normotensive patients, consider lowering blood pressure by approximately 9/4 mmHg provided there is no high-grade carotid stenosis 2
Lipid Management
- Initiate statin therapy immediately for all patients with atherothrombotic TIA, targeting LDL <100 mg/dL, regardless of baseline cholesterol levels 2, 1
- Prescribe AHA Step II diet: 30% calories from fat, <7% from saturated fat, <200mg/day cholesterol 2, 1
- If LDL remains ≥130 mg/dL after 3 months of lifestyle modification, intensify statin therapy 2
Diabetes Management
- Target fasting blood glucose <126 mg/dL (7 mmol/L) 2, 1
- Use diet, regular exercise (at least 3 times weekly), and oral hypoglycemics or insulin as needed 2, 1
Lifestyle Modifications
Smoking Cessation
- All smokers must be counseled on immediate cessation—smoking cessation has major and immediate health benefits 2, 1
- Offer counseling, nicotine replacement therapies, bupropion, and formal smoking cessation programs 2
Weight and Physical Activity
- For BMI >25: Initiate graduated lifestyle change aimed at weight reduction 2, 1
- Prescribe physical activity: At least 10 minutes of exercise (walking, bicycling, running, or swimming) 3-4 times weekly 2, 1
Dietary Modifications
- Advise sodium restriction 2, 1
- Do not recommend antioxidant supplements (vitamins E and C, β-carotene)—they are not effective for cardiovascular disease prevention 2
Carotid Revascularization
Indications for Carotid Endarterectomy
- For symptomatic carotid stenosis 70-99%: Perform carotid endarterectomy within 2 weeks at centers with perioperative complication rates <6% 1
- For symptomatic stenosis 50-69%: Surgery may be indicated for older men with recent hemispheric symptoms and irregular/ulcerated plaque, but only at experienced centers with complication rates <6% 1
Cardiovascular Comorbidity Management
- Evaluate and treat coexistent coronary artery disease, cardiac arrhythmias, congestive heart failure, and valvular heart disease—these conditions substantially affect life expectancy and morbidity in TIA patients 2
Special Considerations
Hormone Replacement Therapy
- Do not use hormone replacement therapy for secondary stroke prevention in postmenopausal women—it may be harmful 2
Patient Education
- Educate all patients to return immediately if symptoms recur—this may represent evolving stroke requiring thrombolytic therapy 1
Common Pitfalls to Avoid
- Never delay antiplatelet therapy while awaiting diagnostic workup 1
- Never use long-term dual antiplatelet therapy (aspirin plus clopidogrel) after TIA 1
- Never start blood pressure medications in the acute phase (first 7-14 days) unless severely elevated, as this may worsen cerebral perfusion 2, 1
- Never perform carotid endarterectomy at centers with perioperative complication rates >6% 1